Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
p110α PI3K and mTOR inhibitor.
MurA and isopentenyl mevalonate kinase inhibito...
Thiazolidinedione; PPARγ agonist.
c-MET inhibitor.
Vitamin D prodrug produced by fungi and alfalfa...
Nucleoside (deoxyuridine) analog; DNA chain ter...
Flavonoid found in Rhus verniciflua and Butea m...
Triazole; demethylation inhibitor, NMDA agonist...
β-lactam carbapenem; penicillin binding protei...
STING agonist
TRPA1 antagonist
NS3/4A inhibitor
NSAID; COX-1/2 inhibitor.
Podophyllotoxin derivative; topoisomerase II in...
Recombinant HCV antigen fragment.
Taxol derivative.
Antioxidant, vitamin E derivative found in vege...
Nucleoside (deoxyguanosine) analog, ganciclovir...
Centrally acting muscle relaxant.
NSAID; COX-1/2 inhibitor.